% Expired Patents = 20.0

EPO Patents = 3

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Thomas N Chase (3 out of 31 patents)

Minako Koga (3 out of 3 patents)

Keishin Sasaki (3 out of 3 patents)

4. Osamu Honmou (2 out of 13 patents)

5. Kazuo Hashi (2 out of 3 patents)

6. Teiji Uede (2 out of 3 patents)

7. Hirofumi Hamada (0 patent)

5 patents: Sort by Forward Citations

1. 10874723 - Cell therapy for the treatment of neurodegeneration (2020-12-29),

2. 10640749 - Mesenchymal stem cell and the method of use thereof (2020-05-05),

3. 10149894 - Cell therapy for the treatment of neurodegeneration (2018-12-11),

4. 10071144 - Cell therapy for the treatment of neurodegeneration (2018-09-11),

5. 9115344 - Mesenchymal stem cell and a method of use thereof (2015-08-25),

Company Overview

NC Medical Research Inc. is a leading medical research company specializing in providing innovative solutions and cutting-edge technology for healthcare providers. Our team of experts is dedicated to advancing medical knowledge and improving patient care through clinical trials and research studies. We are committed to delivering high-quality results and collaborating with healthcare professionals to develop new treatments and therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#2,721 in Tokyo

#6,654 in Japan

Tokyo, Japan

Nc Medical Research Inc.

Forward Citations = 1

6 inventors:

Thomas N Chase (3 out of 31 patents)

Minako Koga (3 out of 3 patents)

Keishin Sasaki (3 out of 3 patents)

4. Osamu Honmou (2 out of 13 patents)

5. Kazuo Hashi (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nc Medical Research Inc.. Retrieved from https://idiyas.com/company/nc-medical-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]